Search - tctmd.com

August 14, 2025

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

August 26, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

January 03, 2024

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

September 14, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

July 28, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

July 20, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

June 23, 2023

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

February 06, 2023

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

November 21, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

October 25, 2022

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

September 30, 2021

News Daily News

New Antithrombotic Revacept Fails to Reduce Myocardial Injury in PCI

April 05, 2021

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

November 03, 2020

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

September 16, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

August 10, 2020

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort